Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Deak

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Chemistry & Biology|October 14, 2014
Two-allergen model reveals complex relationship between IgE crosslinking and degranulationMichael W Handlogten, Peter E Deak, Basar Bilgicer
Scientific Reports|June 23, 2017
Determination of Crucial Immunogenic Epitopes in Major Peanut Allergy Protein, Ara h2, via Novel Nanoallergen PlatformPeter E Deak, Maura R Vrabel, Tanyel Kiziltepe, et al.
The Analyst|July 10, 2014
Affinity-based precipitation via a bivalent peptidic hapten for the purification of monoclonal antibodiesMichael W Handlogten, Jared F Stefanick, Peter E Deak, et al.
Experimental Biology and Medicine (Maywood, N.J.)|May 19, 2016
Nanoallergens: A multivalent platform for studying and evaluating potency of allergen epitopes in cellular degranulationPeter E Deak, Maura R Vrabel, Vincenzo J Pizzuti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 19, 2019
Covalent Heterobivalent Inhibitor Design for Inhibition of IgE-Dependent Penicillin Allergy in a Murine ModelPeter E Deak, Baksun Kim, Byunghee Koh, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 2, 2019
Optimizing design parameters of a peptide targeted liposomal nanoparticle in an in vivo multiple myeloma disease model after initial evaluation in vitroJared F Stefanick, David T Omstead, Jonathan D Ashley, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2019
Designer covalent heterobivalent inhibitors prevent IgE-dependent responses to peanut allergenPeter E Deak, Baksun Kim, Amina Abdul Qayum, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Chemistry & Biology|October 14, 2014
Two-allergen model reveals complex relationship between IgE crosslinking and degranulationMichael W Handlogten, Peter E Deak, Basar Bilgicer
Scientific Reports|June 23, 2017
Determination of Crucial Immunogenic Epitopes in Major Peanut Allergy Protein, Ara h2, via Novel Nanoallergen PlatformPeter E Deak, Maura R Vrabel, Tanyel Kiziltepe, et al.
The Analyst|July 10, 2014
Affinity-based precipitation via a bivalent peptidic hapten for the purification of monoclonal antibodiesMichael W Handlogten, Jared F Stefanick, Peter E Deak, et al.
Experimental Biology and Medicine (Maywood, N.J.)|May 19, 2016
Nanoallergens: A multivalent platform for studying and evaluating potency of allergen epitopes in cellular degranulationPeter E Deak, Maura R Vrabel, Vincenzo J Pizzuti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 19, 2019
Covalent Heterobivalent Inhibitor Design for Inhibition of IgE-Dependent Penicillin Allergy in a Murine ModelPeter E Deak, Baksun Kim, Byunghee Koh, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 2, 2019
Optimizing design parameters of a peptide targeted liposomal nanoparticle in an in vivo multiple myeloma disease model after initial evaluation in vitroJared F Stefanick, David T Omstead, Jonathan D Ashley, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2019
Designer covalent heterobivalent inhibitors prevent IgE-dependent responses to peanut allergenPeter E Deak, Baksun Kim, Amina Abdul Qayum, et al.
Pageof 1